88IV - PR Newswire Asia's news - Health Care/Hospital


Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint BEIJING and SHANGHAI and BOSTON , April 30, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced that the data from the Phase II registrational study of the KRAS G12C inhibitor glecirasib were ... 2024-05-01T Health Care/Hospital Medical/Pharmaceuticals
Integrated cancer biotech Infinitopes secures ￡12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1 ... 2024-05-01T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming Scientific Presentations SAN FRANCISCO and SUZHOU, China , April 30, 2024 /PRNewswire/ -- Eluminex Biosciences (Eluminex), a privately-held biotechnology company focused on the development of advanced protein therapeutics ... 2024-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ambpomial Active Probiotic Yogurt Shines at the European Microbiome and Probiotics Forum, Demonstrating Its Innovative Strength to the World THE HAGUE, Netherlands , April 30, 2024 /PRNewswire/ -- The 12th Microbiome and Probiotics R&D and Business Collaboration Forum was held with great fanfare in The Hague, Netherlands from ... 2024-04-30T Food/Beverages Health Care/Hospital Trade show news
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma SHENZHEN, China , April 30, 2024 /PRNewswire/ -- Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company's lead innovative product Chidamide ... 2024-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Marlabs welcomes Arun Mukunda as Chief Revenue Officer Accelerates focus on Data, AI, and Digital Product Engineering (DPE) in Lifesciences, Banking, and Healthcare ... 2024-04-30T Computer Software Computer/Electronics Health Care/Hospital
A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs NANJING , China , April 30, 2024 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-024, an anti-PD-L1/4-1BB bispecific ... 2024-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance Medison, the creator and leader of the multi-regional ... 2024-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update Delivered solid performance to start 2024, with record-breaking first quarter revenue of 34.1 billion KRW . Strong sales momentum continued from key products, funding investments in ongoing R&D programs. ... 2024-04-30T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
I-MAB Filed 2023 Annual Report on Form 20-F ROCKVILLE, Md. , April 30, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential ... 2024-04-30T Banking/Financial Service Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Health Care/Hospital